Annual Revenue
$71.52 M
+$9.07 M+14.53%
December 31, 2023
Summary
- As of March 7, 2025, OPRX annual revenue is $71.52 million, with the most recent change of +$9.07 million (+14.53%) on December 31, 2023.
- During the last 3 years, OPRX annual revenue has risen by +$28.21 million (+65.13%).
- OPRX annual revenue is now at all-time high.
Performance
OPRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$21.31 M
+$2.50 M+13.27%
September 30, 2024
Summary
- As of March 7, 2025, OPRX quarterly revenue is $21.31 million, with the most recent change of +$2.50 million (+13.27%) on September 30, 2024.
- Over the past year, OPRX quarterly revenue has increased by +$4.98 million (+30.48%).
- OPRX quarterly revenue is now -24.88% below its all-time high of $28.37 million, reached on December 31, 2023.
Performance
OPRX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$88.18 M
+$4.98 M+5.98%
September 30, 2024
Summary
- As of March 7, 2025, OPRX TTM revenue is $88.18 million, with the most recent change of +$4.98 million (+5.98%) on September 30, 2024.
- Over the past year, OPRX TTM revenue has increased by +$25.37 million (+40.40%).
- OPRX TTM revenue is now at all-time high.
Performance
OPRX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
OPRX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.5% | +30.5% | +40.4% |
| 3 y3 years | +65.1% | +4.9% | +43.9% |
| 5 y5 years | +237.3% | +188.8% | +258.5% |
OPRX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +16.7% | -24.9% | +63.9% | at high | +43.9% |
| 5 y | 5-year | at high | +190.8% | -24.9% | +188.8% | at high | +258.5% |
| alltime | all time | at high | >+9999.0% | -24.9% | >+9999.0% | at high | >+9999.0% |
OptimizeRx Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $21.31 M(+13.3%) | $88.18 M(+6.0%) |
| Jun 2024 | - | $18.81 M(-4.5%) | $83.20 M(+6.4%) |
| Mar 2024 | - | $19.69 M(-30.6%) | $78.21 M(+9.3%) |
| Dec 2023 | $71.52 M(+14.5%) | $28.37 M(+73.7%) | $71.52 M(+13.9%) |
| Sep 2023 | - | $16.33 M(+18.2%) | $62.81 M(+2.0%) |
| Jun 2023 | - | $13.82 M(+6.3%) | $61.56 M(-0.3%) |
| Mar 2023 | - | $13.00 M(-33.8%) | $61.72 M(-1.2%) |
| Dec 2022 | $62.45 M(+1.9%) | $19.65 M(+30.3%) | $62.45 M(-1.0%) |
| Sep 2022 | - | $15.09 M(+7.9%) | $63.11 M(-1.6%) |
| Jun 2022 | - | $13.98 M(+1.8%) | $64.15 M(+0.6%) |
| Mar 2022 | - | $13.73 M(-32.4%) | $63.79 M(+4.1%) |
| Dec 2021 | $61.29 M(+41.5%) | $20.31 M(+26.0%) | $61.29 M(+6.8%) |
| Sep 2021 | - | $16.13 M(+18.3%) | $57.41 M(+10.8%) |
| Jun 2021 | - | $13.63 M(+21.3%) | $51.80 M(+10.3%) |
| Mar 2021 | - | $11.23 M(-31.6%) | $46.96 M(+8.4%) |
| Dec 2020 | $43.31 M(+76.1%) | $16.43 M(+56.2%) | $43.31 M(+26.4%) |
| Sep 2020 | - | $10.52 M(+19.8%) | $34.27 M(+19.2%) |
| Jun 2020 | - | $8.78 M(+15.8%) | $28.75 M(+6.6%) |
| Mar 2020 | - | $7.58 M(+2.8%) | $26.97 M(+9.7%) |
| Dec 2019 | $24.60 M(+16.0%) | $7.38 M(+47.5%) | $24.60 M(+3.4%) |
| Sep 2019 | - | $5.00 M(-28.6%) | $23.80 M(-1.7%) |
| Jun 2019 | - | $7.01 M(+34.5%) | $24.21 M(+8.5%) |
| Mar 2019 | - | $5.21 M(-20.8%) | $22.30 M(+5.2%) |
| Dec 2018 | $21.21 M(+74.9%) | $6.58 M(+21.5%) | $21.21 M(+13.8%) |
| Sep 2018 | - | $5.42 M(+6.2%) | $18.63 M(+14.2%) |
| Jun 2018 | - | $5.10 M(+24.0%) | $16.32 M(+15.9%) |
| Mar 2018 | - | $4.11 M(+2.6%) | $14.09 M(+16.2%) |
| Dec 2017 | $12.13 M(+56.5%) | $4.01 M(+29.1%) | $12.13 M(+16.5%) |
| Sep 2017 | - | $3.10 M(+8.3%) | $10.41 M(+14.5%) |
| Jun 2017 | - | $2.87 M(+33.2%) | $9.10 M(+11.7%) |
| Mar 2017 | - | $2.15 M(-6.1%) | $8.14 M(+5.1%) |
| Dec 2016 | $7.75 M | $2.29 M(+28.4%) | $7.75 M(+3.6%) |
| Sep 2016 | - | $1.79 M(-6.6%) | $7.48 M(-2.9%) |
| Jun 2016 | - | $1.91 M(+8.7%) | $7.70 M(+2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $1.76 M(-12.9%) | $7.49 M(+3.8%) |
| Dec 2015 | $7.22 M(+11.0%) | $2.02 M(+0.6%) | $7.22 M(+0.7%) |
| Sep 2015 | - | $2.01 M(+17.7%) | $7.17 M(+2.7%) |
| Jun 2015 | - | $1.71 M(+14.6%) | $6.98 M(+4.2%) |
| Mar 2015 | - | $1.49 M(-24.4%) | $6.70 M(+3.0%) |
| Dec 2014 | $6.50 M(+39.0%) | $1.97 M(+8.1%) | $6.50 M(+7.2%) |
| Sep 2014 | - | $1.82 M(+27.5%) | $6.07 M(+7.9%) |
| Jun 2014 | - | $1.43 M(+10.7%) | $5.62 M(+6.1%) |
| Mar 2014 | - | $1.29 M(-15.9%) | $5.30 M(+13.3%) |
| Dec 2013 | $4.68 M(+135.3%) | $1.53 M(+11.7%) | $4.68 M(+21.9%) |
| Sep 2013 | - | $1.37 M(+24.4%) | $3.84 M(+31.5%) |
| Jun 2013 | - | $1.10 M(+65.0%) | $2.92 M(+25.3%) |
| Mar 2013 | - | $669.30 K(-3.2%) | $2.33 M(+17.1%) |
| Dec 2012 | $1.99 M(+79.0%) | $691.10 K(+52.5%) | $1.99 M(+22.5%) |
| Sep 2012 | - | $453.20 K(-12.1%) | $1.62 M(+19.2%) |
| Jun 2012 | - | $515.40 K(+56.5%) | $1.36 M(+30.1%) |
| Mar 2012 | - | $329.40 K(+1.1%) | $1.05 M(-5.8%) |
| Dec 2011 | $1.11 M(+1463.3%) | $325.90 K(+70.1%) | $1.11 M(+39.3%) |
| Sep 2011 | - | $191.60 K(-4.3%) | $798.00 K(+23.3%) |
| Jun 2011 | - | $200.20 K(-49.2%) | $647.10 K(+39.6%) |
| Mar 2011 | - | $393.80 K(+3075.8%) | $463.60 K(+552.0%) |
| Dec 2010 | $71.10 K(+166.3%) | $12.40 K(-69.5%) | $71.10 K(-3.7%) |
| Sep 2010 | - | $40.70 K(+143.7%) | $73.80 K(+84.5%) |
| Jun 2010 | - | $16.70 K(+1184.6%) | $40.00 K(+49.8%) |
| Mar 2010 | - | $1300.00(-91.4%) | $26.70 K(0.0%) |
| Dec 2009 | $26.70 K(-68.1%) | $15.10 K(+118.8%) | $26.70 K(-1.1%) |
| Sep 2009 | - | $6900.00(+102.9%) | $27.00 K(+27.4%) |
| Jun 2009 | - | $3400.00(+161.5%) | $21.20 K(-38.6%) |
| Mar 2009 | - | $1300.00(-91.6%) | $34.50 K(-58.8%) |
| Dec 2008 | $83.70 K(-16.6%) | $15.40 K(+1300.0%) | $83.70 K(+22.5%) |
| Sep 2008 | - | $1100.00(-93.4%) | $68.30 K(+1.6%) |
| Jun 2008 | - | $16.70 K(-66.9%) | $67.20 K(+33.1%) |
| Mar 2008 | - | $50.50 K | $50.50 K |
| Dec 2007 | $100.30 K | - | - |
FAQ
- What is OptimizeRx annual revenue?
- What is the all time high annual revenue for OptimizeRx?
- What is OptimizeRx annual revenue year-on-year change?
- What is OptimizeRx quarterly revenue?
- What is the all time high quarterly revenue for OptimizeRx?
- What is OptimizeRx quarterly revenue year-on-year change?
- What is OptimizeRx TTM revenue?
- What is the all time high TTM revenue for OptimizeRx?
- What is OptimizeRx TTM revenue year-on-year change?
What is OptimizeRx annual revenue?
The current annual revenue of OPRX is $71.52 M
What is the all time high annual revenue for OptimizeRx?
OptimizeRx all-time high annual revenue is $71.52 M
What is OptimizeRx annual revenue year-on-year change?
Over the past year, OPRX annual revenue has changed by +$9.07 M (+14.53%)
What is OptimizeRx quarterly revenue?
The current quarterly revenue of OPRX is $21.31 M
What is the all time high quarterly revenue for OptimizeRx?
OptimizeRx all-time high quarterly revenue is $28.37 M
What is OptimizeRx quarterly revenue year-on-year change?
Over the past year, OPRX quarterly revenue has changed by +$4.98 M (+30.48%)
What is OptimizeRx TTM revenue?
The current TTM revenue of OPRX is $88.18 M
What is the all time high TTM revenue for OptimizeRx?
OptimizeRx all-time high TTM revenue is $88.18 M
What is OptimizeRx TTM revenue year-on-year change?
Over the past year, OPRX TTM revenue has changed by +$25.37 M (+40.40%)